2m vaccines reserved for second jab – FG

Two million doses of the AstraZeneca COVID-19 vaccine have been reserved for the second dose in the first phase of vaccination, the Federal Government stated yesterday.
It explained with 1,748,242 Nigerians vaccinated as of May 12, 2021, the percentage targeted with the first jab is 86.9 percent.
Noting the vaccination with the second dose of the vaccine has started, it urged persons who have received their first dose of the vaccine to ensure they check their vaccination cards to know when they are due for their second jab.
The Executive Director of the National Primary Health Care Development Agency (NPHCDA), Dr Faisal Shuaib, made these known during a virtual briefing organised by the Africa Centres for Disease Control and Prevention (ACDC) on covid-19 response.
He said: “Vaccination is ongoing across all states. As of today 1,748,242 Nigerians have been vaccinated. This represents 86.9 percent of the number of Nigerians that have been targeted with the first those of the Oxford-AstraZeneca vaccine.
“Due to the current increasing uncertainty in global vaccine supply which is facing our continents and most of the world, Nigeria’s Presidential Steering Committee (PSC) made a strategic choice to utilise our current covid-19 supply to administer double dose rather than single doses.
This will ensure that every Nigerian who receives a vaccine from our present supply, receives their second dose before the recommended time span between doses passes, which is between 6 to 12 weeks.
“Administering these two doses of the vaccine within the recommended time frame is very important to ensure full inoculation benefits.
“This means that with the current supply, we will fully inoculate roughly 2 million Nigerians rather than partially inoculate 4 million Nigerians. We are removing an element of risk that is becoming too high.
“We have already started administering second doses of the Oxford-AstraZeneca vaccine. In addition to health workers, frontline workers aged 18 years and above, and persons aged 50 years and above are being advised to visit any designated vaccination site to receive their vaccine doses whether the first or the second dose